Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
The executive liquidated his entire direct holdings as the stock plunged about 50% from its 52-week high.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.